Working paper - Statistical Analysis Plan
Foot-PAD trial statistical analysis plan, Version 6.0
University of the Sunshine Coast
2021
DOI:
https://doi.org/10.25907/00855
Abstract
To compare the effect of a 12-Week home program of footplate neuromuscular electrical stimulation (Revitive®, footplate NMES) against a footplate placebo control (PCON) in addition to usual care, on change in maximum walking distance during the six-minute walk test, measured at Baseline, Week 6 and Week 12, in people with peripheral artery disease (PAD). Change in maximum walking distance (MWD) during the 6MWT between Baseline and Week 12 is the primary outcome for the trial. The null hypothesis of no difference between groups at 12 Weeks will be tested.
Details
- Title
- Foot-PAD trial statistical analysis plan, Version 6.0
- Authors
- Adrian J Esterman - University of South AustraliaChristopher Askew - University of the Sunshine Coast, Queensland, School of Health - Sports & Exercise Science
- Additional notes
- Australian New Zealand Clinical Trials registration: ACTRN12621001383853
- Publisher
- University of the Sunshine Coast
- Date published
- 2021
- Date updated
- 16-Dec-2024
- DOI
- 10.25907/00855
- Organisation Unit
- Healthy Ageing Research Cluster; Cancer Research Cluster; School of Health - Sports & Exercise Science
- Language
- English
- Record Identifier
- 991041298702621
- Output Type
- Working paper; Statistical Analysis Plan
Metrics
153 File views/ downloads
85 Record Views